New research found no difference in rates of preterm births after adjusting for other risk factors.
Researchers at St. Jude Children’s Research Hospital found that adding a novel anti-disialoganglioside GD2 (anti-GD2) monoclonal antibody to the standard therapy for children newly diagnosed with high-risk neuroblastoma significantly enhanced response to treatment and improved survival. Their findings could be transformative if additional studies can produce similar results.
New retrospective research indicates depression management may lower mortality rates among those with MS.
New data indicates patients report myocarditis at higher rates after the use of immune checkpoint inhibitors during cancer treatment.
Evidence indicates the strongest connection between the vaccination and myocarditis is among males ages 16 to 29.
The link between obesity and cardiovascular health is well established. Until recent years, however, it was unclear whether bariatric surgery could improve morbidity and mortality among obese individuals who had already experienced significant cardiovascular events.
Microbubbles May Boost Response to Transarterial Radioembolization for the Most Common Form of Liver Cancer
In a first-of-its-kind clinical trial, researchers at Thomas Jefferson University demonstrated the safety of combining ultrasound-triggered microbubble destruction and transarterial radioembolization (TARE) to treat patients with hepatocellular carcinoma — and found that combining the therapies was nearly twice as effective as TARE alone.
A recent systematic review found that for patients who underwent pelvic organ prolapse (POP) surgery, pain with sex decreased and overall sexual function improved or was unchanged. The results may inform how surgeons discuss POP surgery with patients.
Three new studies show protein biomarkers can identify Alzheimer’s Disease years before people have symptoms.
Researchers have discovered nontraditional techniques to identify Parkinson’s disease as early as possible, offering hope for patients seeking answers during the early stages of this difficult-to-diagnose neurological condition.
- 1 of 14
- next ›